GET THE APP
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Adalimumab is used to treat people with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis, and children with juvenile idiopathic arthritis. Pharmacokinetic parameters were analyzed for adalimumab and MTX during both phases of the study.
Journals Related to Adalimumab Pharmacokinetics:
Journal of Pharmacokinetics & Experimental Therapeutics, International Journal of Drug Development and Research, Drug Metabolism & Toxicology, Journal of Pharmacokinetics and Biopharmaceutics, Journal of Pharmacokinetics and Pharmacodynamics, Asian Journal of Pharmacodynamics and Pharmacokinetics.